Pubmed | 30898150 |
Title: | Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. |
Year: | 2019 |
DOI: | https://doi.org/10.1186/s13058-019-1127-y |
First Author: | Kennedy |
Experimental setup: | affinity chromatography technology (Biogrid) imaging technique (Biogrid) protein complementation assay (Biogrid) |
Throughput: | High Throughput (Biogrid) Low Throughput (Biogrid) |